TWST

Analyst Sentiment

Wall St. Consensus
Buy
13 analysts·Moderate coverage
69
Score
11 Buy (85%)1 Hold (8%)1 Sell (7%)
Rating Breakdown
Strong Buy
00%
Buy
1185%
Hold
18%
Sell
18%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$52.00
+5.8%
Consensus
$62.50
+27.1%
Bull
$65.00
+32.2%
12-Month Target Range13 analysts
$52.00$62.50$65.00
Current $49.17Consensus
Current Price
$49.17
Upside to Consensus
$13.33

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+16.13%
EPS
FY2028
Rev+14.92%
EPS
FY2029
Rev+13.63%
EPS

Earnings Surprises

Recent Analyst Actions

May 5, 2026Guggenheim
Twist Bioscience price target raised to $60 from $55 at Guggenheim
Target:$60.00
+6.8%from $56.19
May 5, 2026Robert W. Baird
Twist Bioscience price target raised to $65 from $50 at Baird
Target:$65.00
+15.7%from $56.19
May 4, 2026Barclays
Twist Bioscience price target raised to $65 from $55 at Barclays
Target:$65.00
+15.7%from $56.19
Apr 14, 2026Barclays
Twist Bioscience price target raised to $55 from $50 at Barclays
Target:$55.00
+9.2%from $50.38
Feb 3, 2026Robert W. Baird
Twist Bioscience price target raised to $50 from $33 at Baird
Target:$50.00
+4.8%from $47.73
Feb 3, 2026Evercore ISI
Twist Bioscience price target raised to $52 from $42 at Evercore ISI
Target:$52.00
+9.7%from $47.42
Feb 3, 2026Barclays
Twist Bioscience price target raised to $50 from $39 at Barclays
Target:$50.00
+6.8%from $46.81
Jan 5, 2026Evercore ISI
Twist Bioscience price target raised to $42 from $34 at Evercore ISI
Target:$42.00
+22.3%from $34.35
Dec 15, 2025Barclays
Twist Bioscience price target raised to $39 from $37 at Barclays
Target:$39.00
+26.1%from $30.94
Nov 3, 2025Stephens
Twist Bioscience initiated with an Overweight at Stephens
Target:$41.00
+29.9%from $31.57
Oct 2, 2025Barclays
Twist Bioscience price target lowered to $40 from $45 at Barclays
Target:$40.00
+36.7%from $29.26
Aug 4, 2025Evercore ISI
Twist Bioscience price target lowered to $46 from $50 at Evercore ISI
Target:$46.00
+52.3%from $30.21
May 6, 2025Robert W. Baird
Twist Bioscience price target lowered to $44 from $54 at Baird
Target:$44.00
+34.4%from $32.75
Mar 28, 2025Guggenheim
Twist Bioscience price target lowered to $50 from $58 at Guggenheim
Target:$50.00
+23.9%from $40.36
Feb 4, 2025Robert W. Baird
Twist Bioscience price target raised to $54 from $48 at Baird
Target:$54.00
+3.8%from $52.02
Feb 3, 2025Barclays
Twist Bioscience price target raised to $58 from $52 at Barclays
Target:$58.00
+10.0%from $52.75
Sep 17, 2024Robert W. Baird
Baird Reiterates Outperform Rating on Twist Bioscience (TWST)
Target:$46.00
-4.5%from $48.18
Jun 5, 2024Guggenheim
Twist Bioscience initiated with a Buy at Guggenheim (yesterday)
Target:$53.00
+12.8%from $46.98
May 3, 2024Robert W. Baird
Twist Bioscience price target raised to $40 from $39 at Baird
Target:$40.00
+25.0%from $32.01
Jan 17, 2024Goldman Sachs
Goldman Sachs Upgrades Twist Bioscience (TWST) to Buy, 'Express Genes to drive margin expansion'
Target:$45.00
+29.2%from $34.84
Feb 5, 2023Barclays
Twist Bioscience price target lowered to $32 from $37 at Barclays
Target:$32.00
+26.4%from $25.31
Jan 3, 2023Evercore ISI
Evercore ISI Group Upgrades Twist Bioscience to Outperform, Raises Price Target to $36
Target:$36.00
+45.6%from $24.73
Oct 6, 2022Barclays
Twist Bioscience price target lowered to $45 from $55 at Barclays
Target:$45.00
+16.9%from $38.51